10-Q Filing

CARDINAL HEALTH INC CIK: 721371 Q3 2016

Filing Information

Form Type	10-Q
Accession Number	`0000721371-16-000221`
Period End Date	20160331
Filing Date	20160503
Fiscal Year	2016
Fiscal Period	Q3
XBRL Instance	cah-20160331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 88 Cash Flow Statement 78 Comprehensive Income 28

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Preferred shares, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred shares, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred shares, Authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, Authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred shares, Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Common shares, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Common shares, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.87B	USD	Point-in-time
Common shares, Authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, Authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.18B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.60B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.62B	USD	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$7.29B	USD	Point-in-time
Common shares, Issued	`CommonStockSharesIssued`	364.00M	shares	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$6.52B	USD	Point-in-time
Common shares, Issued	`CommonStockSharesIssued`	364.00M	shares	Point-in-time
Inventories, net	`InventoryNet`	$9.21B	USD	Point-in-time
Inventories, net	`InventoryNet`	$10.91B	USD	Point-in-time
Common shares in treasury	`TreasuryStockShares`	36.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockShares`	38.00M	shares	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$1.40B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$1.49B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$22.29B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$21.75B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.68B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.51B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$6.02B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$9.15B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$931.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$866.00M	USD	Point-in-time
Total assets	`Assets`	$30.14B	USD	Point-in-time
Total assets	`Assets`	$34.05B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$17.34B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$14.37B	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$281.00M	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$351.00M	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.59B	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$1.69B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$19.39B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$17.24B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$5.20B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$5.21B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$2.63B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$1.43B	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	-	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$117.00M	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized755 million shares, Issued364 million shares at March 31, 2016 and June 30, 2015	`CommonStockValue`	$3.00B	USD	Point-in-time
Authorized755 million shares, Issued364 million shares at March 31, 2016 and June 30, 2015	`CommonStockValue`	$3.00B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$5.52B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$6.23B	USD	Point-in-time
Common shares in treasury, at cost: 38 million shares and 36 million shares at March 31, 2016 and June 30, 2015, respectively	`TreasuryStockValue`	$2.25B	USD	Point-in-time
Common shares in treasury, at cost: 38 million shares and 36 million shares at March 31, 2016 and June 30, 2015, respectively	`TreasuryStockValue`	$2.43B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-84.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-23.00M	USD	Point-in-time
Total Cardinal Health, Inc. shareholder's equity	`StockholdersEquity`	$6.71B	USD	Point-in-time
Total Cardinal Health, Inc. shareholder's equity	`StockholdersEquity`	$6.26B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	-	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$17.00M	USD	Point-in-time
Total shareholder's equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.73B	USD	Point-in-time
Total shareholder's equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.26B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests, and shareholders equity	`LiabilitiesAndStockholdersEquity`	$34.05B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests, and shareholders equity	`LiabilitiesAndStockholdersEquity`	$30.14B	USD	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$90.16B	USD	3 Qtrs
Revenue	`Revenues`	$25.38B	USD	1 Quarter
Revenue	`Revenues`	$30.66B	USD	1 Quarter
Revenue	`Revenues`	$74.98B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsSold`	$70.73B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsSold`	$28.97B	USD	1 Quarter
Cost of products sold	`CostOfGoodsSold`	$85.28B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsSold`	$23.92B	USD	1 Quarter
Gross margin	`GrossProfit`	$4.25B	USD	3 Qtrs
Gross margin	`GrossProfit`	$4.88B	USD	3 Qtrs
Gross margin	`GrossProfit`	$1.46B	USD	1 Quarter
Gross margin	`GrossProfit`	$1.69B	USD	1 Quarter
Distribution, selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.68B	USD	3 Qtrs
Distribution, selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.39B	USD	3 Qtrs
Distribution, selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$914.00M	USD	1 Quarter
Distribution, selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$803.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$19.00M	USD	3 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$6.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$7.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$33.00M	USD	3 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$190.00M	USD	3 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$77.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$327.00M	USD	3 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$108.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$19.00M	USD	3 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	-	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$1.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-17.00M	USD	3 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-5.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$3.00M	USD	3 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$18.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-54.00M	USD	3 Qtrs
Operating earnings	`OperatingIncomeLoss`	$591.00M	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$1.84B	USD	3 Qtrs
Operating earnings	`OperatingIncomeLoss`	$656.00M	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$1.60B	USD	3 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$-5.00M	USD	3 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$6.00M	USD	3 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$2.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Interest expense, net	`InterestExpense`	$35.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$44.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$134.00M	USD	3 Qtrs
Interest expense, net	`InterestExpense`	$105.00M	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-60.00M	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$612.00M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$558.00M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.70B	USD	3 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.44B	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$524.00M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$193.00M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$226.00M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$604.00M	USD	3 Qtrs
Net Earnings	`ProfitLoss`	$1.10B	USD	3 Qtrs
Net Earnings	`ProfitLoss`	$920.00M	USD	3 Qtrs
Net Earnings	`ProfitLoss`	$365.00M	USD	1 Quarter
Net Earnings	`ProfitLoss`	$386.00M	USD	1 Quarter
Net earnings attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net earnings attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net earnings attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	3 Qtrs
Net earnings attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$365.00M	USD	1 Quarter
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$1.09B	USD	3 Qtrs
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$920.00M	USD	3 Qtrs
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$386.00M	USD	1 Quarter
Net basic earnings per common share (in dollars per share)	`EarningsPerShareBasic`	$3.33	USD	3 Qtrs
Net basic earnings per common share (in dollars per share)	`EarningsPerShareBasic`	$1.18	USD	1 Quarter
Net basic earnings per common share (in dollars per share)	`EarningsPerShareBasic`	$1.10	USD	1 Quarter
Net basic earnings per common share (in dollars per share)	`EarningsPerShareBasic`	$2.77	USD	3 Qtrs
Net diluted earnings per common share (in dollars per share)	`EarningsPerShareDiluted`	$1.09	USD	1 Quarter
Net diluted earnings per common share (in dollars per share)	`EarningsPerShareDiluted`	$3.30	USD	3 Qtrs
Net diluted earnings per common share (in dollars per share)	`EarningsPerShareDiluted`	$2.74	USD	3 Qtrs
Net diluted earnings per common share (in dollars per share)	`EarningsPerShareDiluted`	$1.17	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	328.00M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	332.00M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	330.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	328.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	336.00M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	334.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	331.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	331.00M	shares	3 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.39	USD	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$1.03	USD	3 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$1.16	USD	3 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.34	USD	1 Quarter

Cash Flow Statement 78 line items

Line Item	Tag	Value	Unit	Period
Net Earnings	`ProfitLoss`	$1.10B	USD	3 Qtrs
Net Earnings	`ProfitLoss`	$920.00M	USD	3 Qtrs
Net Earnings	`ProfitLoss`	$365.00M	USD	1 Quarter
Net Earnings	`ProfitLoss`	$386.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$465.00M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$336.00M	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-60.00M	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Gain on sale of other investments	`GainOnSaleOfInvestments`	-	USD	3 Qtrs
Gain on sale of other investments	`GainOnSaleOfInvestments`	$5.00M	USD	3 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$19.00M	USD	3 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	-	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$1.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-17.00M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$80.00M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$82.00M	USD	3 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$51.00M	USD	3 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$42.00M	USD	3 Qtrs
Change in fair value of contingent consideration obligation	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	-	USD	3 Qtrs
Change in fair value of contingent consideration obligation	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-16.00M	USD	3 Qtrs
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$721.00M	USD	3 Qtrs
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$718.00M	USD	3 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$850.00M	USD	3 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$1.46B	USD	3 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.66B	USD	3 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.84B	USD	3 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-169.00M	USD	3 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$26.00M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.67B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.33B	USD	3 Qtrs
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.38B	USD	3 Qtrs
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$319.00M	USD	3 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$284.00M	USD	3 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$139.00M	USD	3 Qtrs
Purchase of available-for-sale securities and other investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$150.00M	USD	3 Qtrs
Purchase of available-for-sale securities and other investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$134.00M	USD	3 Qtrs
Proceeds from sale of available-for-sale securities and other investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$99.00M	USD	3 Qtrs
Proceeds from sale of available-for-sale securities and other investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$129.00M	USD	3 Qtrs
Proceeds from maturities of available-for-sale securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$24.00M	USD	3 Qtrs
Proceeds from maturities of available-for-sale securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$37.00M	USD	3 Qtrs
Proceeds from divestitures and disposal of held for sale assets	`Proceedsfromdivestituresanddisposalofheldforsaleassets`	-	USD	3 Qtrs
Proceeds from divestitures and disposal of held for sale assets	`Proceedsfromdivestituresanddisposalofheldforsaleassets`	$53.00M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-386.00M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.68B	USD	3 Qtrs
Payment of contingent consideration obligation	`PaymentofContingentConsideration`	$23.00M	USD	3 Qtrs
Payment of contingent consideration obligation	`PaymentofContingentConsideration`	$3.00M	USD	3 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$-9.00M	USD	3 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$34.00M	USD	3 Qtrs
Purchase of noncontrolling interests	`PaymentsToAcquireAdditionalInterestInSubsidiaries`	$10.00M	USD	3 Qtrs
Purchase of noncontrolling interests	`PaymentsToAcquireAdditionalInterestInSubsidiaries`	-	USD	3 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$5.00M	USD	3 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$1.22B	USD	3 Qtrs
Proceeds from long-term obligations, net of issuance costs	`ProceedsFromDebtNetOfIssuanceCosts`	$1.18B	USD	3 Qtrs
Proceeds from long-term obligations, net of issuance costs	`ProceedsFromDebtNetOfIssuanceCosts`	-	USD	3 Qtrs
Net proceeds/(tax withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-3.00M	USD	3 Qtrs
Net proceeds/(tax withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$59.00M	USD	3 Qtrs
Excess tax benefits from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$56.00M	USD	3 Qtrs
Excess tax benefits from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$33.00M	USD	3 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$346.00M	USD	3 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$386.00M	USD	3 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$300.00M	USD	3 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$686.00M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-660.00M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-968.00M	USD	3 Qtrs
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	-	USD	3 Qtrs
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-7.00M	USD	3 Qtrs
Net increase/(decrease) in cash and equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.02B	USD	3 Qtrs
Net increase/(decrease) in cash and equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$318.00M	USD	3 Qtrs
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.87B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.18B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.60B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.62B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.87B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.18B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.60B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.62B	USD	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net Earnings	`ProfitLoss`	$1.10B	USD	3 Qtrs
Net Earnings	`ProfitLoss`	$920.00M	USD	3 Qtrs
Net Earnings	`ProfitLoss`	$365.00M	USD	1 Quarter
Net Earnings	`ProfitLoss`	$386.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-53.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-57.00M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-117.00M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00M	USD	1 Quarter
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$2.00M	USD	1 Quarter
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-3.00M	USD	1 Quarter
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-4.00M	USD	3 Qtrs
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-6.00M	USD	3 Qtrs
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-123.00M	USD	3 Qtrs
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-51.00M	USD	1 Quarter
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$13.00M	USD	1 Quarter
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-61.00M	USD	3 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$399.00M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$314.00M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$797.00M	USD	3 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.03B	USD	3 Qtrs
Comprehensive income/(loss), net of tax attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Comprehensive income/(loss), net of tax attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Comprehensive income/(loss), net of tax attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$1.00M	USD	3 Qtrs
Comprehensive income/(loss), net of tax attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$399.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$1.03B	USD	3 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$797.00M	USD	3 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$314.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.